Estramustine phosphate
Drug profile
Also known as: emcyt, estramustine phosphate sodium
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Estramustine phosphate is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1981. DrugCentral lists 5 molecular targets, including PTPN11, INPPL1 and PTPN6.
- Approval status: ofm (first approved 1981 by the FDA).
- Molecular targets: PTPN11, INPPL1, PTPN6 and PTPN1 (5 listed in DrugCentral).
- Molecular formula: C23H32Cl2NO6P; molecular weight 520.38 g/mol.
Mechanism & targets
Molecular targets (5)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Tyrosine-protein phosphatase non-receptor type 11 | PTPN11 | unknown | Kd 5.08 |
| Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 | INPPL1 | unknown | IC50 4.45 |
| Protein-tyrosine phosphatase 1C | PTPN6 | unknown | IC50 4.39 |
| Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | unknown | IC50 4.20 |
| Estrogen receptor beta | ESR2 | modulator | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1981-12-24 | FDA | — | PHARMACIA AND UPJOHN |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Osteonecrosis of jaw | 94.6 |
Chemical structure
| Molecular formula | C23H32Cl2NO6P |
|---|---|
| Molecular weight | 520.38 g/mol |
| CAS number | 4891-15-0 |
| InChIKey | ADFOJJHRTBFFOF-RBRWEJTLSA-N |
| PubChem CID | 259329 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Estramustine phosphate work?
Its molecular targets in DrugCentral include PTPN11, INPPL1, PTPN6 and PTPN1.
When was Estramustine phosphate first approved?
Estramustine phosphate was first approved by the FDA in 1981.
What is the chemical formula of Estramustine phosphate?
Estramustine phosphate has the molecular formula C23H32Cl2NO6P and a molecular weight of 520.38 g/mol.
Browse: all drugs starting with E · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1066 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1200721 — compound record and bioactivity
- PubChem CID 259329 — chemical identifiers
- DrugBank DB14674 — drug record
- FDA UNII MUZ9585Y7B — substance identity
- DailyMed: FDA labels for Estramustine phosphate — current prescribing information (label search)
- UniProt Q06124 (PTPN11) — target protein
- UniProt O15357 (INPPL1) — target protein
- UniProt P29350 (PTPN6) — target protein
- UniProt P18031 (PTPN1) — target protein
- UniProt Q92731 (ESR2) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.